Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70518-4343

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-4343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4cd7b19c D80f 4c80 8795 F4c9566ab59a 01)

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of bupropion HCI extended-release tablets with a strength of 300mg. The medication is manufactured by Rising Pharma, Inc. and should be stored between 20-25°C (68-77°F). It is important to keep this medication out of reach of children. A warning is given not to use this medication in combination with Zyban or any other medicines containing bupropion hydrochloride. This product comes in a package quantity of 30 blisters. The usual dosage and other important information can be found in the insert provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.